Talking to the Moon: World’s First Multimodal Foundation Model for Lunar Exploration and Resources

The same AI methods that power ChatGPT can now allow you to talk to the Moon Its good to be skeptical when applying ...
PharmTech

EMA and FDA Collaborate on Framework for AI Use in Drug Development

FDA and EMA have issued 10 guiding principles for AI in drug development with the intended goal of ensuring safety and ...
BMJ Open

Participatory development of an evaluation and data model for teleconsultations in long-term care: study protocol based on the MRC framework

Introduction Demographic change is resulting in a growing number of individuals requiring nursing care, while the ...
SiliconANGLE

Microsoft debuts Windows AI Foundry for local model development on AI PCs

Microsoft Corp. said today it’s advancing the local artificial intelligence development capabilities of Windows, as part of an effort to help developers build and experiment and reach new users with ...

AI model identifies how every country can improve its cancer outcomes

For the first time, researchers have used machine learning—a type of artificial intelligence (AI)—to identify the most ...
EurekAlert!

Data-model fusion: applications of key technology in smart manufacturing and digital engineering

In the rapidly evolving landscape of modern manufacturing and engineering, a new technology is emerging as a crucial enabler-Data-Model Fusion (DMF). A recent review paper published in Engineering ...

MongoDB combines database and embedding models for simplified AI development

MongoDB said additional partners and offerings are expected to be added to the startup program over time.

$1.5 Billion AI-based Clinical Trials Market 2026-2032: Rising Investment from Biopharma Sponsors and CROs

The "AI-based Clinical Trials Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The AI-based clinical trials market is driving a fundamental transformation in ...
FierceBiotech

Tempus AI in line for $200M from AstraZeneca, Pathos deal to develop cancer model

Tempus AI has signed a three-way deal with AstraZeneca and Pathos AI to construct a data-based oncology model that could ultimately be used to develop new cancer drugs. Tempus will use its “vast ...